tabcin
- Product NDC
- 69729-836
- Requested package NDC
- 69729-836-20
- 11-digit product format
- 697290836
- Labeler code
- 69729
- Product ID
- 69729-836_5d5cf5fa-cdc5-563e-e063-6294a90aee3a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Dextromethorphan HBr, Guaifenesin
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- OPMX LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-09-07
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 20; 400 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- tabcin
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 20 mg/1 |
| GUAIFENESIN | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1661740 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 23223821-4fa0-5d99-e063-6394a90af0e5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks DayQuil and Vicks NyQuil Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 4147ff00-8e21-7335-e054-00144ff88e88 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | d1657403-b953-4db1-9a86-343e9e769a1a | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | a17d0de4-85d1-47b7-ba72-3672ea65b397 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Kids ALLERGY | DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 2f9a6d65-f849-af0a-e063-6394a90ae435 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil ALLERGY | DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 2f9b3bbb-4494-065d-e063-6294a90afcd2 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Alcohol Free Cold and Flu Nighttime Relief | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | ec57c15e-cb6d-44a9-e053-2a95a90ae774 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil ULTRA CONCENTRATED COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | ff0a4054-0745-f649-e053-6394a90af904 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil NyQuil ULTRA CONCENTRATED COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | ff356128-95ea-0fbe-e053-6294a90adcb8 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil ULTRA CONCENTRATED COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | febabad6-0bf0-a3f8-e053-6294a90a3aeb | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Severe and Vicks NyQuil Severe Cold and Flu | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 9003df61-5d82-5c4d-e053-2995a90a8999 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Severe Cold and Flu | ACETAMINOPHEN, PHENYLEPHINE HCL, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | 6f013cc1-7885-5025-e053-2a91aa0afe11 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Severe Cold and Flu | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 6eef8a59-2f8a-1a90-e053-2a91aa0a1d52 | 2026-10-05 | Warnings | M012 |
| VICKS VapoRub | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, MENTHOL | Procter & Gamble Manufactura S de RL de CV | 0a3086b7-a670-474e-81cf-8f989af425c2 | 2026-10-05 | Warnings | M012 |
| Vicks VapoRub | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL | Procter & Gamble Manufactura S de RL de CV | 699691ae-d2a1-a8bb-e053-2991aa0acfea | 2026-10-05 | Warnings | M012 |
| Vicks childrens VapoRub | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, MENTHOL | Procter & Gamble Manufactura S de RL de CV | 00f2fd0e-2608-6c06-e063-6294a90a066a | 2026-10-05 | Warnings | M012 |
| Vicks VapoRub | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL | Procter & Gamble Manufactura S de RL de CV | 699879f9-4a7e-3680-e053-2a91aa0a44af | 2026-10-05 | Warnings | M012 |
| Vicks VapoRub ADVANCED PLUS | CAMPHOR, EUCALYPTUS OIL, MENTHOL | Procter & Gamble Manufacturing GmbH | f801128c-94bb-fa9e-e053-6294a90a0822 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | 5bbe271e-0344-4926-991c-3115756b908e | 2026-10-05 | Warnings | M012 |
| Vicks Formula 44DM HONEY COUGH and CHEST CONGESTION | DEXTROMETHORPHAN HBR, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 3258067b-8e32-2b4a-e063-6394a90a7433 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Kids Cold Cough plus Mucus | GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | c6f13d96-5136-63a0-e053-2a95a90af6dc | 2026-10-05 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1661740 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Capsule | PSN | 23223821-4fa0-5d99-e063-6394a90af0e5 | 2 |
| 1661740 | dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Capsule | SCD | 23223821-4fa0-5d99-e063-6394a90af0e5 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69729-836-20 | 69729083620 | 1 BLISTER PACK in 1 CARTON (69729-836-20) / 20 CAPSULE, LIQUID FILLED in 1 BLISTER PACK | 1 blister pack | 2026-09-07 | No | No | Current |